Compositions for therapeutic percutaneous embolization and the use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 3, 1989
Grant Date -
N/A
app pub date -
May 6, 1987
filing date -
May 6, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Percutaneous emboli are formed for therapeutic and/or corrective reasons by using a composition which includes crosslinked gells of hyaluronic acid (HA), hylan (HY) or mixed crosslinked gels of HA or HY with other materials, thrombin and cationic substances containing quaternary ammonium groups. Other optional materials include fillers and radio-opaque substances.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully